New drug LP-003 takes first step against stubborn hives
NCT ID NCT06604949
First seen Jan 03, 2026 · Last updated May 25, 2026 · Updated 18 times
Summary
This study tests a single dose of LP-003 in 12 healthy adults to see if it is safe and how the body processes it. The drug is being developed to help people with chronic spontaneous urticaria, a condition causing long-term hives and itching. The main goal is to check for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.